April 14 - 16, 2026
Austria Center Vienna
11:05 – EC M&A
11:20 – Carrier
11:35 – ABC Plan
FOR: The operational resilience of the global pharma supply chain has been proven and globalized supply chains are the only cost-effective means of ensuring ongoing supply
AGAINST: A fundamental revaluation of the E2E supply chain, a move towards near-shoring, and regional API and finished product manufacturing is required to ensure future operational resilience